trial

Evaluation of Generalization Paradigm Patterns Among Different Psychiatric Disorders

NCTId NCT01501812

as of 2026-07-01

Add to landscape Monitor this Ask about this

at a glance

Phase — · Unknown

Enrollment 180 (estimated)

Sponsored by Shalvata Mental Health Center

Primary completion 2012-12

Synthesized from structured facts only — each point cited above.

Design & status

Phase

—

Status

Unknown

Enrollment

180 (estimated)

Study type

Observational

Allocation

—

Model

—

Masking

—

Start

2011-03

Primary completion

2012-12

Eligibility

ALL · 20 Years · 65 Years

Interventions & indications

Drugs

Generalization pattern

Indications

MDD Bipolar Disorder Anxiety Disorder (Panic Disorder or GAD)Generalized Anxiety Disorder Schizophrenia Disorder Bipolar Disorder Panic Disorder Schizophrenia PTSD Stress Disorders, Post-Traumatic Anxiety Disorders

Investigators

Shahak Yariv, MDPrincipal Investigator

Sites

1 total

Hod HaSharon, Israel

Facts & assertions

4 sourced

Enrollment

180

Phase

Primary Completion Date

2012-12

Status

UNKNOWN

relationships

The graph out of here

drug

Generalization pattern

drug

lead_sponsor

Shalvata Mental Health Center

company

collaborator

Weizmann Institute of Science

company

indication

MDD

indication

Bipolar Disorder

indication

Anxiety Disorder (Panic Disorder or GAD)

indication

investigator

Shahak Yariv, MD

person